Transcatheter occlusive therapy of genitourinary abnormalities using isobutyl 2-cyanoacrylate (Bucrylate).
Transcatheter occlusive therapy was performed with isobutyl 2-cyanoacrylate (Bucrylate) in 14 patients with a variety of genitourinary abnormalities. Bucrylate was found to be a valuable agent when used to: (1) occlude vessels with very slow flow; (2) occlude vessels in patients with coagulopathies; (3) occlude high flow arteriovenous fistulas; (4) perform superselective vessel occlusion; and (5) produce permanent vessel obliteration. Bucrylate was used effectively in this group of patients and was used without complications or evidence of histotoxicity.
D000328:Adult; D000368:Aged; D001164:Arteriovenous Fistula / Q000628:therapy*; D002015:Bucrylate / Q000627:therapeutic use*; D002404:Catheterization / Q000379:methods; D003487:Cyanoacrylates / Q000627:therapeutic use*; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy*; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010386:Pelvic Neoplasms / Q000628:therapy*
D003487:Cyanoacrylates; D002015:Bucrylate